Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 287 is a non-coding pseudogene, meaning it is a DNA sequence that resembles the functional RN7SK gene but is generally considered non-functional and does not produce a functional RNA or protein product[7]. "RN7SK" itself encodes a small nuclear RNA involved in transcriptional regulation, but the pseudogene (RN7SKP287) is most likely a genomic remnant with no known biological, disease, or therapeutic relevance[7]. There is no evidence that RN7SKP287 is considered a receptor, enzyme, transporter, transcription factor, or any therapeutic target, nor that it interacts with drugs or serves any biomarker or safety concern function[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 287 (RN7SKP287).